Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Galloway JB"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 24
Tytuł:
Changing trends in ethnicity and academic performance: observational cohort data from a UK medical school.
Autorzy:
Mukherji P; Marketing Department, King's College London, London, UK.
Adas MA; Centre for Rheumatic Diseases, King's College London, London, UK.
Clarke B; Postgraduate Medical & Dental Education Centre, King's College Hospital NHS Foundation Trust, London, UK.
Galloway JB; Centre for Rheumatic Diseases, King's College London, London, UK james.galloway@kcl.ac.uk.
Mulvey T; Clinical Education Department, King's College London, London, UK.
Norton S; Psychology Department, Insitute of Psychiatry, King's College London, London, UK.
Turner J; Clinical Education Department, King's College London, London, UK.
Russell MD; Centre for Rheumatic Diseases, King's College London, London, UK.
Lempp H; Centre for Rheumatic Diseases, King's College London, London, UK.
Li S; Division of Medical Education, King's College London, London, UK.
Pokaż więcej
Źródło:
BMJ open [BMJ Open] 2022 Dec 15; Vol. 12 (12), pp. e066886. Date of Electronic Publication: 2022 Dec 15.
Typ publikacji:
Observational Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Schools, Medical*
Students, Medical*
Adult ; Female ; Humans ; Adolescent ; Male ; Ethnicity ; Educational Measurement ; United Kingdom
Czasopismo naukowe
Szczegóły
Tytuł:
Vaccine hesitancy and access to psoriasis care during the COVID-19 pandemic: findings from a global patient-reported cross-sectional survey.
Autorzy:
Bechman K; Centre for Rheumatic Diseases, King's College London, London, UK.
Cook ES; Centre for Rheumatic Diseases, King's College London, London, UK.
Dand N; Department of Medical and Molecular Genetics, School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.; Health Data Research UK, London, UK.
Yiu ZZN; Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK.
Tsakok T; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
Meynell F; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
Coker B; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
Vincent A; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
Bachelez H; Department of Dermatology, AP-HP Hôpital Saint-Louis, Paris, France.; INSERM U1163, Imagine Institute for Human Genetic Diseases, Université de Paris, Paris, France.
Barbosa I; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
Brown MA; Centre for Rheumatic Diseases, King's College London, London, UK.; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
Capon F; Department of Medical and Molecular Genetics, School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
Contreras CR; Catedra de Dermatologia, Hospital de Clinicas, Facultad de Ciencias Medicas, Universidad Nacional de Asuncion, Paraguay.
De La Cruz C; Clinica Dermacross, Santiago, Chile.
Meglio PD; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.; St John's Institute of Dermatology, School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King's College London, London, UK.
Gisondi P; Section of Dermatology and Venereology, University of Verona, Verona, Italy.
Jullien D; Department of Dermatology, Edouard Herriot Hospital, Hospices Civils de Lyon, University of Lyon, Lyon, France.; Groupe de recherche sur le psoriasis (GrPso) de la Société Française de dermatologie, Paris, France.
Kelly J; Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK.
Lambert J; Department of Dermatology, Ghent University, Ghent, Belgium.
Lancelot C; International Federation of Psoriasis Associations.
Langan SM; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.; Faculty of Epidemiology, and Population Health, London School of Hygiene and Tropical Medicine, London, UK.
Mason KJ; Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK.; School of Medicine, Keele University, Keele, UK.
McAteer H; The Psoriasis Association, Northampton, UK.
Moorhead L; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
Naldi L; Centro Studi GISED, Bergamo, Italy.
Norton S; Psychology Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
Puig L; Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.
Spuls PI; Department of Dermatology, Amsterdam Public Health/Infection and Immunology, Amsterdam University Medical Centers, Location AMC, Amsterdam, the Netherlands.
Torres T; Department of Dermatology, Centro Hospitalar do Porto, Portugal.
Urmston D; The Psoriasis Association, Northampton, UK.
Vesty A; The Psoriasis Association, Northampton, UK.
Warren RB; Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK.
Waweru H; International Federation of Psoriasis Associations.
Weinman J; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
Griffiths CEM; Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK.
Barker JN; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.; St John's Institute of Dermatology, School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King's College London, London, UK.
Smith CH; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
Galloway JB; Centre for Rheumatic Diseases, King's College London, London, UK.
Mahil SK; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
Pokaż więcej
Corporate Authors:
PsoProtect study group
Źródło:
The British journal of dermatology [Br J Dermatol] 2022 Aug; Vol. 187 (2), pp. 254-256. Date of Electronic Publication: 2022 May 03.
Typ publikacji:
Letter
MeSH Terms:
COVID-19*/prevention & control
Psoriasis*/drug therapy
Cross-Sectional Studies ; Humans ; Pandemics ; Patient Reported Outcome Measures ; Vaccination ; Vaccination Hesitancy
Opinia redakcyjna
Szczegóły
Tytuł:
Management of gout following 2016/2017 European (EULAR) and British (BSR) guidelines: An interrupted time-series analysis in the United Kingdom.
Autorzy:
Russell MD; Centre for Rheumatic Diseases, King's College London, SE5 9RJ, UK.
Rutherford AI; Department of Rheumatology, King's College Hospital NHS Foundation Trust, London, SE5 9RS, UK.
Ellis B; Department of Rheumatology, Imperial College Healthcare NHS Foundation Trust, London.
Norton S; Centre for Rheumatic Diseases, King's College London, SE5 9RJ, UK.
Douiri A; School of Population Health and Environmental Sciences, King's College London, SE1 1UL, UK.
Gulliford MC; School of Population Health and Environmental Sciences, King's College London, SE1 1UL, UK.
Cope AP; Centre for Rheumatic Diseases, King's College London, SE5 9RJ, UK.
Galloway JB; Centre for Rheumatic Diseases, King's College London, SE5 9RJ, UK.
Pokaż więcej
Źródło:
The Lancet regional health. Europe [Lancet Reg Health Eur] 2022 May 25; Vol. 18, pp. 100416. Date of Electronic Publication: 2022 May 25 (Print Publication: 2022).
Typ publikacji:
Journal Article
Czasopismo naukowe
Szczegóły
Tytuł:
Inpatient COVID-19 mortality has reduced over time: Results from an observational cohort.
Autorzy:
Bechman K; Centre for Rheumatic Diseases, King's College London, London, United Kingdom.
Yates M; Centre for Rheumatic Diseases, King's College London, London, United Kingdom.
Mann K; Centre for Rheumatic Diseases, King's College London, London, United Kingdom.
Nagra D; Centre for Rheumatic Diseases, King's College London, London, United Kingdom.
Smith LJ; King's College Hospital NHS Foundation Trust, London, United Kingdom.
Rutherford AI; King's College Hospital NHS Foundation Trust, London, United Kingdom.
Patel A; King's College Hospital NHS Foundation Trust, London, United Kingdom.
Periselneris J; King's College Hospital NHS Foundation Trust, London, United Kingdom.
Walder D; King's College Hospital NHS Foundation Trust, London, United Kingdom.
Dobson RJB; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.; NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, United Kingdom.; Health Data Research UK London, University College London, London, United Kingdom.
Kraljevic Z; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Teo JHT; King's College Hospital NHS Foundation Trust, London, United Kingdom.; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Bernal W; King's College Hospital NHS Foundation Trust, London, United Kingdom.; School of Immunology and Microbial Sciences, King's College London, London, United Kingdom.
Barker R; Centre for Rheumatic Diseases, King's College London, London, United Kingdom.
Galloway JB; Centre for Rheumatic Diseases, King's College London, London, United Kingdom.
Norton S; Centre for Rheumatic Diseases, King's College London, London, United Kingdom.; Psychology Department, King's College London, London, United Kingdom.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Jan 13; Vol. 17 (1), pp. e0261142. Date of Electronic Publication: 2022 Jan 13 (Print Publication: 2022).
Typ publikacji:
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19/*mortality
Hospital Mortality/*trends
Inpatients/*statistics & numerical data
Adenosine Monophosphate/analogs & derivatives ; Adenosine Monophosphate/therapeutic use ; Aged ; Alanine/analogs & derivatives ; Alanine/therapeutic use ; Cohort Studies ; Comorbidity/trends ; Dexamethasone/therapeutic use ; Female ; Hospitalization/statistics & numerical data ; Humans ; London ; Male ; Middle Aged ; Pandemics/statistics & numerical data ; Patient Discharge/statistics & numerical data ; Proportional Hazards Models ; COVID-19 Drug Treatment
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional study.
Autorzy:
Mahil SK; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
Yates M; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.; Centre for Rheumatic Diseases, King's College London, London, UK.
Yiu ZZN; Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK.
Langan SM; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.; Faculty of Epidemiology, and Population Health, London School of Hygiene and Tropical Medicine, London, UK.
Tsakok T; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
Dand N; Department of Medical and Molecular Genetics, School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.; Health Data Research UK, London, UK.
Mason KJ; Centre for Rheumatic Diseases, King's College London, London, UK.; School of Medicine, Keele University, Keele, UK.
McAteer H; The Psoriasis Association, Northampton, UK.
Meynell F; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
Coker B; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
Vincent A; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
Urmston D; The Psoriasis Association, Northampton, UK.
Vesty A; The Psoriasis Association, Northampton, UK.
Kelly J; Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK.
Lancelot C; International Federation of Psoriasis Associations (IFPA), Bromma, Sweden.
Moorhead L; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
Bachelez H; Department of Dermatology, AP-HP Hôpital Saint-Louis, Paris, France.; INSERM U1163, Imagine Institute for Human Genetic Diseases, Université de Paris, Paris, France.
Capon F; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.; Department of Medical and Molecular Genetics, School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
Contreras CR; Catedra de Dermatologia, Hospital de Clinicas, Facultad de Ciencias Medicas, Universidad Nacional de Asuncion, San Lorenzo, Paraguay.
De La Cruz C; Clinica Dermacross, Santiago, Chile.
Di Meglio P; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.; St John's Institute of Dermatology, School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King's College London, London, UK.
Gisondi P; Section of Dermatology and Venereology, University of Verona, Verona, Italy.
Jullien D; Department of Dermatology, Edouard Herriot Hospital, Hospices Civils de Lyon, University of Lyon, Lyon, France.; Groupe de Recherche sur le Psoriasis (GrPso) de la Société Française de Dermatologie, Paris, France.
Lambert J; Department of Dermatology, Ghent University, Ghent, Belgium.
Naldi L; Centro Studi GISED, Bergamo, Italy.
Norton S; Psychology Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Puig L; Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
Spuls P; Department of Dermatology, Amsterdam Public Health/Infection and Immunology, Amsterdam University Medical Centers, Location AMC, Amsterdam, The Netherlands.
Torres T; Department of Dermatology, Centro Hospitalar do Porto, Porto, Portugal.
Warren RB; Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK.
Waweru H; International Federation of Psoriasis Associations (IFPA), Bromma, Sweden.
Weinman J; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
Brown MA; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.; Centre for Rheumatic Diseases, King's College London, London, UK.
Galloway JB; Centre for Rheumatic Diseases, King's College London, London, UK.; Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK.
Griffiths CM; Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK.
Barker JN; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.; St John's Institute of Dermatology, School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King's College London, London, UK.
Smith CH; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
Pokaż więcej
Corporate Authors:
PsoProtect study group
Źródło:
Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2021 Oct; Vol. 35 (10), pp. e636-e640. Date of Electronic Publication: 2021 Aug 19.
Typ publikacji:
Letter
MeSH Terms:
COVID-19*
Psoriasis*/epidemiology
Cross-Sectional Studies ; Humans ; Pandemics ; SARS-CoV-2
Opinia redakcyjna
Szczegóły
Tytuł:
Nonserious Infections in Patients With Rheumatoid Arthritis: Results From the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
Autorzy:
Bechman K; Kings College London, London, UK.
Halai K; Kings College London, London, UK.
Yates M; Kings College London, London, UK.
Norton S; Kings College London, London, UK.
Cope AP; Kings College London, London, UK.
Hyrich KL; Manchester Academic Health Sciences Centre, University of Manchester, NIHR Manchester Biomedical Research Centre, and Manchester University NHS Foundation Trust, Manchester, UK.
Galloway JB; Kings College London, London, UK.
Pokaż więcej
Corporate Authors:
British Society for Rheumatology Biologics Register for Rheumatoid Arthritis Contributors Group
Źródło:
Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2021 Oct; Vol. 73 (10), pp. 1800-1809. Date of Electronic Publication: 2021 Aug 17.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antirheumatic Agents/*therapeutic use
Arthritis, Rheumatoid/*epidemiology
Biological Products/*therapeutic use
Infections/*epidemiology
Tumor Necrosis Factor Inhibitors/*therapeutic use
Adult ; Aged ; Arthritis, Rheumatoid/drug therapy ; Comorbidity ; Female ; Humans ; Incidence ; Male ; Middle Aged ; Registries ; United Kingdom/epidemiology
Czasopismo naukowe
Szczegóły
Tytuł:
Risk-mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient survey.
Autorzy:
Mahil SK
Yates M
Langan SM
Yiu ZZN
Tsakok T
Dand N
Mason KJ
McAteer H
Meynell F
Coker B
Vincent A
Urmston D
Vesty A
Kelly J
Lancelot C
Moorhead L
Bachelez H
Bruce IN
Capon F
Contreras CR
Cope AP
De La Cruz C
Di Meglio P
Gisondi P
Hyrich K
Jullien D
Lambert J
Marzo-Ortega H
McInnes I
Naldi L
Norton S
Puig L
Sengupta R
Spuls P
Torres T
Warren RB
Waweru H
Weinman J
Griffiths CEM
Barker JN
Brown MA
Galloway JB
Smith CH
Pokaż więcej
Corporate Authors:
PsoProtect, CORE-UK study groups
Źródło:
The British journal of dermatology [Br J Dermatol] 2021 Jul; Vol. 185 (1), pp. 80-90. Date of Electronic Publication: 2021 Mar 09.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*
Joint Diseases*
Cross-Sectional Studies ; Humans ; Male ; Pandemics ; SARS-CoV-2
Czasopismo naukowe
Szczegóły
Tytuł:
A Kawasaki-like illness in an adult with recent SARS-CoV-2 infection.
Autorzy:
Nagra D; Centre for Rheumatic Disease, King's College London.
Russell MD; Centre for Rheumatic Disease, King's College London.
Rosmini S; King's College Hospital NHS Foundation Trust, London, UK.
Sado D; King's College Hospital NHS Foundation Trust, London, UK.
Buazon A; Centre for Rheumatic Disease, King's College London.
Shafi T; King's College Hospital NHS Foundation Trust, London, UK.
Hamlyn E; King's College Hospital NHS Foundation Trust, London, UK.
Sandhu G; King's College Hospital NHS Foundation Trust, London, UK.
Rutherford AI; King's College Hospital NHS Foundation Trust, London, UK.
Galloway JB; Centre for Rheumatic Disease, King's College London.
Pokaż więcej
Źródło:
Rheumatology advances in practice [Rheumatol Adv Pract] 2021 May 18; Vol. 5 (2), pp. rkab035. Date of Electronic Publication: 2021 May 18 (Print Publication: 2021).
Typ publikacji:
Journal Article
Czasopismo naukowe
Szczegóły
Tytuł:
Biological responses to COVID-19: Insights from physiological and blood biomarker profiles.
Autorzy:
Zakeri R; King's College London British Heart Foundation Centre of Excellence, School of Cardiovascular Medicine & Sciences, London, SE5 9NU, UK; King's College Hospital NHS Foundation Trust, London, UK.
Pickles A; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK.
Carr E; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Bean DM; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; Health Data Research UK London, University College London, London, UK.
O'Gallagher K; King's College London British Heart Foundation Centre of Excellence, School of Cardiovascular Medicine & Sciences, London, SE5 9NU, UK.
Kraljewic Z; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Searle T; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK.
Shek A; Department of Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Galloway JB; Centre for Rheumatic Diseases, King's College London, London, UK.
Teo JTH; King's College Hospital NHS Foundation Trust, London, UK; Department of Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Shah AM; King's College London British Heart Foundation Centre of Excellence, School of Cardiovascular Medicine & Sciences, London, SE5 9NU, UK; King's College Hospital NHS Foundation Trust, London, UK.
Dobson RJB; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK; Institute of Health Informatics, University College London, London, UK; NIHR Biomedical Research Centre at University College London Hospitals NHS Foundation Trust, London, UK.
Bendayan R; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK. Electronic address: .
Pokaż więcej
Źródło:
Current research in translational medicine [Curr Res Transl Med] 2021 May; Vol. 69 (2), pp. 103276. Date of Electronic Publication: 2021 Feb 03.
Typ publikacji:
Journal Article
MeSH Terms:
Biomarkers/*blood
COVID-19/*diagnosis
COVID-19/*epidemiology
COVID-19/*physiopathology
Aged ; Aged, 80 and over ; Biological Variation, Individual ; Body Temperature ; COVID-19/blood ; Cohort Studies ; Comorbidity ; Diagnostic Tests, Routine ; Disease Progression ; Female ; Heart Rate/physiology ; Humans ; Male ; Middle Aged ; Oxygen Consumption/physiology ; Prognosis ; Retrospective Studies ; Risk Assessment ; SARS-CoV-2/immunology ; SARS-CoV-2/pathogenicity ; Severity of Illness Index ; Socioeconomic Factors ; United Kingdom/epidemiology
Czasopismo naukowe
Szczegóły
Tytuł:
IL-6 inhibition in the treatment of COVID-19: A meta-analysis and meta-regression.
Autorzy:
Tharmarajah E; Centre for Rheumatic Diseases, Weston Education Centre, King's College London, 10 Cutcombe Road, London SE5 9RJ, UK.
Buazon A; Centre for Rheumatic Diseases, Weston Education Centre, King's College London, 10 Cutcombe Road, London SE5 9RJ, UK.
Patel V; Centre for Rheumatic Diseases, Weston Education Centre, King's College London, 10 Cutcombe Road, London SE5 9RJ, UK.
Hannah JR; Centre for Rheumatic Diseases, Weston Education Centre, King's College London, 10 Cutcombe Road, London SE5 9RJ, UK.
Adas M; Centre for Rheumatic Diseases, Weston Education Centre, King's College London, 10 Cutcombe Road, London SE5 9RJ, UK.
Allen VB; Centre for Rheumatic Diseases, Weston Education Centre, King's College London, 10 Cutcombe Road, London SE5 9RJ, UK.
Bechman K; Centre for Rheumatic Diseases, Weston Education Centre, King's College London, 10 Cutcombe Road, London SE5 9RJ, UK.
Clarke BD; Centre for Rheumatic Diseases, Weston Education Centre, King's College London, 10 Cutcombe Road, London SE5 9RJ, UK.
Nagra D; Centre for Rheumatic Diseases, Weston Education Centre, King's College London, 10 Cutcombe Road, London SE5 9RJ, UK.
Norton S; Centre for Rheumatic Diseases, Weston Education Centre, King's College London, 10 Cutcombe Road, London SE5 9RJ, UK.
Russell MD; Centre for Rheumatic Diseases, Weston Education Centre, King's College London, 10 Cutcombe Road, London SE5 9RJ, UK. Electronic address: .
Rutherford AI; Centre for Rheumatic Diseases, Weston Education Centre, King's College London, 10 Cutcombe Road, London SE5 9RJ, UK.
Yates M; Centre for Rheumatic Diseases, Weston Education Centre, King's College London, 10 Cutcombe Road, London SE5 9RJ, UK.
Galloway JB; Centre for Rheumatic Diseases, Weston Education Centre, King's College London, 10 Cutcombe Road, London SE5 9RJ, UK.
Pokaż więcej
Źródło:
The Journal of infection [J Infect] 2021 May; Vol. 82 (5), pp. 178-185. Date of Electronic Publication: 2021 Mar 18.
Typ publikacji:
Journal Article; Meta-Analysis
MeSH Terms:
COVID-19*
Interleukin-6*
Adult ; Humans ; Male ; Odds Ratio ; SARS-CoV-2
Czasopismo naukowe
Szczegóły
Tytuł:
Venous Thromboembolism Risk With JAK Inhibitors: A Meta-Analysis.
Autorzy:
Yates M; King's College London, London, UK.
Mootoo A; King's College London, London, UK.
Adas M; King's College London, London, UK.
Bechman K; King's College London, London, UK.
Rampes S; King's College London, London, UK.
Patel V; King's College London, London, UK.
Qureshi S; King's College London, London, UK.
Cope AP; King's College London, London, UK.
Norton S; King's College London, London, UK.
Galloway JB; King's College London, London, UK.
Pokaż więcej
Źródło:
Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2021 May; Vol. 73 (5), pp. 779-788. Date of Electronic Publication: 2021 Mar 25.
Typ publikacji:
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
MeSH Terms:
Janus Kinase Inhibitors/*therapeutic use
Pulmonary Embolism/*epidemiology
Venous Thromboembolism/*epidemiology
Venous Thrombosis/*epidemiology
Arthritis, Psoriatic/drug therapy ; Arthritis, Rheumatoid/drug therapy ; Azetidines/therapeutic use ; Clinical Trials, Phase II as Topic ; Clinical Trials, Phase III as Topic ; Heterocyclic Compounds, 3-Ring/therapeutic use ; Humans ; Inflammatory Bowel Diseases/drug therapy ; Piperidines/therapeutic use ; Psoriasis/drug therapy ; Purines/therapeutic use ; Pyrazoles/therapeutic use ; Pyridines/therapeutic use ; Pyrimidines/therapeutic use ; Randomized Controlled Trials as Topic ; Risk ; Spondylarthropathies/drug therapy ; Spondylitis, Ankylosing/drug therapy ; Sulfonamides/therapeutic use ; Triazoles/therapeutic use
Czasopismo naukowe
Szczegóły
Tytuł:
Remote Measurement in Rheumatoid Arthritis: Qualitative Analysis of Patient Perspectives.
Autorzy:
White KM; Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Ivan A; Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Williams R; Department of Academic Rheumatology, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.
Galloway JB; The Centre for Rheumatic Diseases, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.
Norton S; The Centre for Rheumatic Diseases, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.; Department of Psychology, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Matcham F; Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Pokaż więcej
Źródło:
JMIR formative research [JMIR Form Res] 2021 Mar 09; Vol. 5 (3), pp. e22473. Date of Electronic Publication: 2021 Mar 09.
Typ publikacji:
Journal Article
Czasopismo naukowe
Szczegóły
Tytuł:
Chest radiography is a poor predictor of respiratory symptoms and functional impairment in survivors of severe COVID-19 pneumonia.
Autorzy:
D'Cruz RF; Centre for Human and Applied Physiological Sciences, King's College London, London, UK.
Waller MD; Centre for Human and Applied Physiological Sciences, King's College London, London, UK.; Dept of Respiratory Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Perrin F; Dept of Respiratory Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Periselneris J; Dept of Respiratory Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Norton S; Centre for Rheumatic Disease, King's College London, London, UK.
Smith LJ; Dept of Respiratory Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Patrick T; Dept of Respiratory Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Walder D; Dept of Respiratory Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Heitmann A; Dept of Respiratory Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Lee K; Dept of Respiratory Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Madula R; Dept of Respiratory Medicine, King's College Hospital NHS Foundation Trust, London, UK.
McNulty W; Dept of Respiratory Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Macedo P; Dept of Respiratory Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Lyall R; Dept of Respiratory Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Warwick G; Dept of Respiratory Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Galloway JB; Centre for Rheumatic Disease, King's College London, London, UK.
Birring SS; Centre for Human and Applied Physiological Sciences, King's College London, London, UK.; Dept of Respiratory Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Patel A; Dept of Respiratory Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Patel I; Centre for Human and Applied Physiological Sciences, King's College London, London, UK.; Dept of Respiratory Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Jolley CJ; Centre for Human and Applied Physiological Sciences, King's College London, London, UK.; Dept of Respiratory Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Pokaż więcej
Źródło:
ERJ open research [ERJ Open Res] 2021 Feb 08; Vol. 7 (1). Date of Electronic Publication: 2021 Feb 08 (Print Publication: 2021).
Typ publikacji:
Journal Article
Czasopismo naukowe
Szczegóły
Tytuł:
Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report.
Autorzy:
Buckland MS; Department of Clinical Immunology, Barts Health, London, UK. .; UCL GOSH Institute of Child Health Division of Infection and Immunity, Section of Cellular and Molecular Immunology, London, UK. .
Galloway JB; Centre for Rheumatic Diseases, King's College London, London, UK.
Fhogartaigh CN; Department of Infection, Barts Health NHS Trust, London, UK.
Meredith L; Department of Pathology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
Provine NM; Peter Medawar Building for Pathogen Research, South Parks Rd, Oxford, OX1 3SY, UK.; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
Bloor S; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK.
Ogbe A; Peter Medawar Building for Pathogen Research, South Parks Rd, Oxford, OX1 3SY, UK.; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
Zelek WM; Systems Immunity Institute and Dementia Research Institute, Cardiff University, Cardiff, UK.
Smielewska A; Division of Virology, Department of Pathology, University of Cambridge, Addenbrookes Hospital, Cambridge, UK.; PHE - Public Health England Laboratory, Cambridge. Box 236, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK.
Yakovleva A; Department of Pathology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
Mann T; Medical Research Council Toxicology Unit, University of Cambridge, Gleeson Building, Tennis Court Road, Cambridge, CB2 1QW, UK.
Bergamaschi L; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK.
Turner L; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK.
Mescia F; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK.
Toonen EJM; R&D Department, Hycult Biotechnology, Frontstraat 2A, 5405 PB, Uden, The Netherlands.
Hackstein CP; Peter Medawar Building for Pathogen Research, South Parks Rd, Oxford, OX1 3SY, UK.; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
Akther HD; Peter Medawar Building for Pathogen Research, South Parks Rd, Oxford, OX1 3SY, UK.; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
Vieira VA; Peter Medawar Building for Pathogen Research, South Parks Rd, Oxford, OX1 3SY, UK.; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
Ceron-Gutierrez L; Department of Clinical Biochemistry and Immunology, Addenbrooke's Hospital, Cambridge, UK.
Periselneris J; Respiratory Department, King's College Hospital NHS Foundation Trust, UK. Department of Clinical Virology, Addenbrookes, UK.
Kiani-Alikhan S; Department of Clinical Immunology, Barts Health, London, UK.
Grigoriadou S; Department of Clinical Immunology, Barts Health, London, UK.
Vaghela D; Department of Infectious Diseases, Cambridge University Hospitals NHS Trust, Cambridge, UK.
Lear SE; Department of Immunology, Cambridge University Hospitals NHS Trust, Cambridge, UK.
Török ME; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.; Cambridge University Hospitals NHS Foundation Trust, Department of Microbiology, Cambridge, UK.
Hamilton WL; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Stockton J; Institute of Microbiology and Infection, University of Birmingham, Birmingham, UK.
Quick J; Institute of Microbiology and Infection, University of Birmingham, Birmingham, UK.
Nelson P; Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK.
Hunter M; Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK.
Coulter TI; Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK.; Regional Immunology Service, Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK.
Devlin L; Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK.; Regional Immunology Service, Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK.
Bradley JR; NIHR BioResource and NIHR Cambridge Biomedical Research Centre, Cambridge Biomedical Campus, Cambridge, UK.
Smith KGC; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK.
Ouwehand WH; Department of Haematology, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK.; NHS Blood and Transplant, Cambridge Biomedical Campus, Cambridge, UK.
Estcourt L; NHS Blood and Transplant, Oxford, UK.
Harvala H; NHS Blood and Transplant, London, UK.
Roberts DJ; NHS Blood and Transplant, Oxford, UK.; Radcliffe Department of Medicine and BRC Haematology Theme, University of Oxford, John Radcliffe Hospital, Oxford, UK.
Wilkinson IB; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK.
Screaton N; Radiology, Papworth Hospital, Cambridge, UK.
Loman N; Institute of Microbiology and Infection, University of Birmingham, Birmingham, UK.
Doffinger R; Respiratory Department, King's College Hospital NHS Foundation Trust, UK. Department of Clinical Virology, Addenbrookes, UK.
Lyons PA; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK.
Morgan BP; Systems Immunity Institute and Dementia Research Institute, Cardiff University, Cardiff, UK.
Goodfellow IG; Department of Pathology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
Klenerman P; Peter Medawar Building for Pathogen Research, South Parks Rd, Oxford, OX1 3SY, UK.; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
Lehner PJ; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK.; Department of Infectious Diseases, Cambridge University Hospitals NHS Trust, Cambridge, UK.
Matheson NJ; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK. .; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK. .; Department of Infectious Diseases, Cambridge University Hospitals NHS Trust, Cambridge, UK. .; NHS Blood and Transplant, Cambridge Biomedical Campus, Cambridge, UK. .
Thaventhiran JED; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK. .; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK. .; Medical Research Council Toxicology Unit, University of Cambridge, Gleeson Building, Tennis Court Road, Cambridge, CB2 1QW, UK. .; Cancer Research UK Cambridge Institute, Cambridge Biomedical Campus, Cambridge, UK. .
Pokaż więcej
Corporate Authors:
CITIID-NIHR COVID-19 BioResource Collaboration
MRC-Toxicology Unit COVID-19 Consortium
Źródło:
Nature communications [Nat Commun] 2020 Dec 14; Vol. 11 (1), pp. 6385. Date of Electronic Publication: 2020 Dec 14.
Typ publikacji:
Case Reports; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Adenosine Monophosphate/*analogs & derivatives
Alanine/*analogs & derivatives
Immunity, Humoral/*drug effects
SARS-CoV-2/*drug effects
Adenosine Monophosphate/therapeutic use ; Adult ; Alanine/therapeutic use ; Antiviral Agents/therapeutic use ; COVID-19/virology ; Fever/prevention & control ; Humans ; Immunity, Humoral/immunology ; Lymphocyte Count ; Male ; SARS-CoV-2/immunology ; SARS-CoV-2/physiology ; Treatment Outcome
Czasopismo naukowe
Szczegóły
Tytuł:
A systematic review of CXCL13 as a biomarker of disease and treatment response in rheumatoid arthritis.
Autorzy:
Bechman K; Centre of Rheumatic Diseases, Weston Education Centre, King's College London, Room 3.46, Third Floor, London, SE5 9RJ, UK. .
Dalrymple A; Centre of Rheumatic Diseases, Weston Education Centre, King's College London, Room 3.46, Third Floor, London, SE5 9RJ, UK.
Southey-Bassols C; Centre of Rheumatic Diseases, Weston Education Centre, King's College London, Room 3.46, Third Floor, London, SE5 9RJ, UK.
Cope AP; Centre of Rheumatic Diseases, Weston Education Centre, King's College London, Room 3.46, Third Floor, London, SE5 9RJ, UK.
Galloway JB; Centre of Rheumatic Diseases, Weston Education Centre, King's College London, Room 3.46, Third Floor, London, SE5 9RJ, UK.
Pokaż więcej
Źródło:
BMC rheumatology [BMC Rheumatol] 2020 Nov 02; Vol. 4 (1), pp. 70. Date of Electronic Publication: 2020 Nov 02.
Typ publikacji:
Journal Article
Czasopismo naukowe
Szczegóły
Tytuł:
How achievable are COVID-19 clinical trial recruitment targets? A UK observational cohort study and trials registry analysis.
Autorzy:
Cunniffe NG; Department of Clinical Neurosciences, Cambridge University, Cambridge, UK.
Gunter SJ; Harvard Medical School, Harvard University, Boston, Massachusetts, USA.
Brown M; Division of Infection, University College London Hospital NHS Trust, London, UK.
Burge SW; Cancer Research UK Urological Malignancies Programme, Department of Oncology, University of Cambridge, Cambridge, UK.
Coyle C; Department of Cardiology, Hammersmith Hospitals NHS Trust, London, UK.
De Soyza A; Respiratory Medicine, Freeman Hospital, Newcastle upon Tyne, UK.
Dymond T; Department of Infection and Inflammation Research, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Esmail H; Hospital for Tropical Diseases, University College London Hospitals NHS Foundation Trust, London, UK.; MRC Clinical Trials Unit, University College London, London, UK.; Institute for Global Health, University College London, London, United Kingdom.
Francis DP; Faculty of Medicine, National Heart & Lung Institute, Imperial College London, London, UK.
Galloway J; Department of Respiratory Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Galloway JB; Centre for Rheumatic Diseases, Kings College London, London, UK.
Gkrania-Klotsas E; Department of Infectious Diseases, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Greenaway J; Research and Development, North Tees Hospital, Stockton-on-Tees, UK.
Katritsis G; National Heart and Lung Institute, Imperial College London, London, UK.
Kanagaratnam P; Department of Cardiology, St Marys Hospital, Imperial College Healthcare NHS Trust, London, UK.
Knolle MD; Department of Respiratory Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Leonard K; Cambridge Urology Translational Research and Clinical Trials Department, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
McIntyre ZC; School of Clinical Medicine, Office for Translational Research, University of Cambridge, Cambridge, UK.
Prudon B; Department of Respiratory Medicine, North Tees Hospital, Stockton-on-Tees, UK.
Rampling T; Division of Pathology, University College London Hospital NHS Trust, London, United Kingdom.
Torok ME; University of Cambridge, Cambridge, UK.
Warne B; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, UK.
Yates M; Centre for Rheumatic Diseases, Kings College London, London, UK.
Matheson NJ; Department of Infectious Diseases, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, UK.; NHS Blood and Transplant, Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.
Su L; MRC Biostatistics Unit, University of Cambridge School of Clinical Medicine, Cambridge Institute of Public Health, Cambridge, United Kingdom.
Villar S; MRC Biostatistics Unit, University of Cambridge School of Clinical Medicine, Cambridge Institute of Public Health, Cambridge, United Kingdom.
Stewart GD; Cancer Research UK Urological Malignancies Programme, Department of Oncology, University of Cambridge, Cambridge, UK.; Department of Surgery, University of Cambridge, Cambridge, UK.
Toshner M; Department of Medicine, University of Cambridge, Cambridge, UK .; NIHR Respiratory Translational Research Collaboration, Cambridge, UK.
Pokaż więcej
Źródło:
BMJ open [BMJ Open] 2020 Oct 05; Vol. 10 (10), pp. e044566. Date of Electronic Publication: 2020 Oct 05.
Typ publikacji:
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Biomedical Research*/organization & administration
Biomedical Research*/statistics & numerical data
Coronavirus Infections*/epidemiology
Coronavirus Infections*/therapy
Pandemics*
Patient Selection*
Pneumonia, Viral*/epidemiology
Pneumonia, Viral*/therapy
Randomized Controlled Trials as Topic*/methods
Randomized Controlled Trials as Topic*/statistics & numerical data
Betacoronavirus/isolation & purification ; COVID-19 ; Eligibility Determination ; Female ; Health Services Accessibility/statistics & numerical data ; Hospitalization/statistics & numerical data ; Humans ; Male ; Middle Aged ; Prospective Studies ; Registries/statistics & numerical data ; SARS-CoV-2 ; United Kingdom
Czasopismo naukowe
Szczegóły
Tytuł:
The clinical effectiveness of intensive management in moderate established rheumatoid arthritis: The titrate trial.
Autorzy:
Scott D; Centre for Rheumatic Diseases, Department of Inflammation Biology, School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London Cutcombe Road, London, SE5 9RJ, United Kingdom.
Ibrahim F; Centre for Rheumatic Diseases, Department of Inflammation Biology, School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London Cutcombe Road, London, SE5 9RJ, United Kingdom. Electronic address: .
Hill H; ScHARR Health Economics and Decision Science, The University of Sheffield, Regent Court, 30 Regent Street, Sheffield, S1 4DA, United Kingdom.
Tom B; MRC Biostatistics Unit, University of Cambridge, Cambridge Institute of Public Health, Forvie Site, Robinson Way, Cambridge Biomedical Campus, Cambridge, CB2 0SR, United Kingdom.
Prothero L; Centre for Rheumatic Diseases, Department of Inflammation Biology, School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London Cutcombe Road, London, SE5 9RJ, United Kingdom.
Baggott RR; Centre for Rheumatic Diseases, Department of Inflammation Biology, School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London Cutcombe Road, London, SE5 9RJ, United Kingdom.
Bosworth A; National Rheumatoid Arthritis Society (NRAS), Switchback Office Park, Gardner Rd, Maidenhead, SL6 7RJ, United Kingdom.
Galloway JB; Centre for Rheumatic Diseases, Department of Inflammation Biology, School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London Cutcombe Road, London, SE5 9RJ, United Kingdom.
Georgopoulou S; Centre for Rheumatic Diseases, Department of Inflammation Biology, School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London Cutcombe Road, London, SE5 9RJ, United Kingdom.
Martin N; Centre for Rheumatic Diseases, Department of Inflammation Biology, School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London Cutcombe Road, London, SE5 9RJ, United Kingdom.
Neatrour I; Centre for Rheumatic Diseases, Department of Inflammation Biology, School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London Cutcombe Road, London, SE5 9RJ, United Kingdom.
Nikiphorou E; Centre for Rheumatic Diseases, Department of Inflammation Biology, School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London Cutcombe Road, London, SE5 9RJ, United Kingdom.
Sturt J; Department Of Adult Nursing, Florence Nightingale Faculty of Nursing, Midwifery & Palliative Care, King's College London, James Clerk Maxwell Building, 57 Waterloo Road, London SE1 8WA, United Kingdom.
Wailoo A; ScHARR Health Economics and Decision Science, The University of Sheffield, Regent Court, 30 Regent Street, Sheffield, S1 4DA, United Kingdom.
Williams FMK; Twin Research & Genetic Epidemiology, School of Life Course Sciences, King's College London, St Thomas' Hospital, London SE1 7EH, United Kingdom.
Williams R; Centre for Rheumatic Diseases, Department of Inflammation Biology, School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London Cutcombe Road, London, SE5 9RJ, United Kingdom.
Lempp H; Centre for Rheumatic Diseases, Department of Inflammation Biology, School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London Cutcombe Road, London, SE5 9RJ, United Kingdom.
Pokaż więcej
Źródło:
Seminars in arthritis and rheumatism [Semin Arthritis Rheum] 2020 Oct; Vol. 50 (5), pp. 1182-1190. Date of Electronic Publication: 2020 Jul 30.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Antirheumatic Agents*/therapeutic use
Arthritis, Rheumatoid*/drug therapy
Fatigue ; Humans ; Treatment Outcome
Czasopismo naukowe
Szczegóły
Tytuł:
A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: An observational cohort study.
Autorzy:
Galloway JB; Centre for Rheumatic Disease, King's College London, London, United Kingdom. Electronic address: james.galloway@kcl.ac.uk.
Norton S; Centre for Rheumatic Disease, King's College London, London, United Kingdom.
Barker RD; Department of Respiratory Medicine, King's College Hospital, London, United Kingdom.
Brookes A; Department of Emergency Medicine, King's College Hospital, London, United Kingdom.
Carey I; Institute of Liver Studies, King's College Hospital, London, United Kingdom.
Clarke BD; Centre for Rheumatic Disease, King's College London, London, United Kingdom.
Jina R; Department of Emergency Medicine, King's College Hospital, London, United Kingdom.
Reid C; Department of Emergency Medicine, King's College Hospital, London, United Kingdom.
Russell MD; Centre for Rheumatic Disease, King's College London, London, United Kingdom.
Sneep R; Department of Emergency Medicine, King's College Hospital, London, United Kingdom.
Sugarman L; Department of Emergency Medicine, King's College Hospital, London, United Kingdom.
Williams S; Department of Emergency Medicine, King's College Hospital, London, United Kingdom.
Yates M; Centre for Rheumatic Disease, King's College London, London, United Kingdom.
Teo J; Department of Neurosciences, King's College Hospital, London, United Kingdom.
Shah AM; School of Cardiovascular Medicine & Sciences, King's College London British Heart Foundation Centre, London, United Kingdom.
Cantle F; Department of Emergency Medicine, King's College Hospital, London, United Kingdom.
Pokaż więcej
Źródło:
The Journal of infection [J Infect] 2020 Aug; Vol. 81 (2), pp. 282-288. Date of Electronic Publication: 2020 May 29.
Typ publikacji:
Journal Article; Observational Study
MeSH Terms:
Coronavirus Infections/*mortality
Critical Care/*statistics & numerical data
Hospitalization/*statistics & numerical data
Pneumonia, Viral/*mortality
Adult ; Aged ; Aged, 80 and over ; Betacoronavirus ; COVID-19 ; Cohort Studies ; Comorbidity ; Coronavirus Infections/diagnostic imaging ; Electronic Health Records ; Female ; Humans ; London/epidemiology ; Male ; Middle Aged ; Pandemics ; Pneumonia, Viral/diagnostic imaging ; Radiography ; Risk Factors ; SARS-CoV-2 ; Thorax/diagnostic imaging ; Young Adult
Czasopismo naukowe
Szczegóły
Tytuł:
Data quality predicts care quality: findings from a national clinical audit.
Autorzy:
Yates M; The Centre for Rheumatic Diseases, School of Immunology, Infection & Inflammatory Disease, King's College London, Room 3.46 Weston Education Centre, Cutcombe Road, London, SE5 9RJ, UK. .
Bechman K; The Centre for Rheumatic Diseases, School of Immunology, Infection & Inflammatory Disease, King's College London, Room 3.46 Weston Education Centre, Cutcombe Road, London, SE5 9RJ, UK.
Dennison EM; MRC Epidemiology Unit, University of Southampton, Southampton, UK.
MacGregor AJ; Norwich Medical School, University of East Anglia, Norwich, UK.
Ledingham J; Department of Rheumatology, Queen Alexandra Hospital, Portsmouth, UK.
Norton S; Institute of Psychiatry, Kings College London, London, UK.
Galloway JB; The Centre for Rheumatic Diseases, School of Immunology, Infection & Inflammatory Disease, King's College London, Room 3.46 Weston Education Centre, Cutcombe Road, London, SE5 9RJ, UK.
Pokaż więcej
Źródło:
Arthritis research & therapy [Arthritis Res Ther] 2020 Apr 17; Vol. 22 (1), pp. 87. Date of Electronic Publication: 2020 Apr 17.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Data Accuracy*
Medical Audit*
Quality of Health Care*
Arthritis, Rheumatoid/*drug therapy
Adult ; Aged ; Antirheumatic Agents/therapeutic use ; Cohort Studies ; England ; Female ; Humans ; Male ; Middle Aged ; Observational Studies as Topic ; Wales
Czasopismo naukowe
Szczegóły
Wyświetlanie 1-20 z 24

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz